Now Is A Suitable Moment For A Long-Term Purchase Of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
Currently, there are 96.27M common shares owned by the public and among those 90.35M shares have been available to trade. The company’s stock has a 5-day price change of -11.86% and -16.45% over the past three months. AVDL shares are trading -6.87% year to date (YTD), with the 12-month market performance up to 23.36% higher. […]
Analysts Update Their Price Forecasts For Avadel Pharmaceuticals plc (AVDL)
Avadel Pharmaceuticals plc (AVDL) concluded trading on Thursday at a closing price of $15.47, with 5.11 million shares of worth about $79.08 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.46% during that period and on October 31, 2024 the price saw a […]
